SCHEMBL14218032

SCHEMBL14218032

CCN1CCN(C(=O)CCCCC2CCCCC2)CC1

nearest known ligand 0.81

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 2/20 0.81
▸ SIGMAR1 Q99720 1/20 0.55
▸ NAAA Q02083 1/20 0.52
▸ ALDH1A1 P00352 3/20 0.50
▸ ATM Q13315 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ GAA P10253 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ GNAI3 P08754 2/20 0.48
▸ GNAO1 P09471 2/20 0.48
▸ GNAI1 P63096 2/20 0.48
▸ ITGB3 P05106 1/20 0.45
▸ ITGA2B P08514 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22940447 0.84 ATM (0.59) HSD11B1SIGMAR1NAAAALDH1A1ATM
SCHEMBL7371370 0.84 ATM (0.59) HSD11B1SIGMAR1NAAAALDH1A1ATM
SCHEMBL4377326 0.82 HSD11B1 (0.55) HSD11B1SIGMAR1NAAAALDH1A1ATM
SCHEMBL4382883 0.81 KMT2A (0.59) HSD11B1SIGMAR1NAAAALDH1A1ATM
SCHEMBL4382097 0.81 KMT2A (0.59) HSD11B1SIGMAR1NAAAALDH1A1ATM
SCHEMBL25447312 0.79 HSD11B1 (0.57) HSD11B1NAAAALDH1A1ATMTP53
SCHEMBL4382989 0.78 HSD11B1 (0.78) HSD11B1ALDH1A1ATMTP53GAA
SCHEMBL23471439 0.77 L3MBTL1 (0.69) HSD11B1NAAAALDH1A1L3MBTL1MEN1
SCHEMBL12128801 0.77 MEN1 (0.74) HSD11B1SIGMAR1NAAAALDH1A1ATM
SCHEMBL2828741 0.77 MEN1 (0.74) HSD11B1SIGMAR1NAAAALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113968-A1 Substituted piperazines and diazepanes HRH3, HRH4, HRH1 HSD11B1 2071/4885SIGMAR1 237/4885NAAA 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback